Risk factors for drug-resistant epilepsy in adult patients.
Anti-seizure medications
Anticonvulsivos
Drug-resistant epilepsy
Drug-sensitive epilepsy
Epilepsia farmacorresistente
Epilepsia refractaria
Epilepsia sensible a fármacos
Farmacorresistencia
Pharmacoresistance
Refractory epilepsy
Journal
Medicina clinica
ISSN: 1578-8989
Titre abrégé: Med Clin (Barc)
Pays: Spain
ID NLM: 0376377
Informations de publication
Date de publication:
23 06 2023
23 06 2023
Historique:
received:
16
01
2023
revised:
10
03
2023
accepted:
15
03
2023
medline:
13
6
2023
pubmed:
13
4
2023
entrez:
12
4
2023
Statut:
ppublish
Résumé
Drug-resistant epilepsy occurs in about 30% of epilepsy patients. It has been suggested that etiology or seizure type would increase the risk of pharmacoresistance. This study aims to compare the characteristics of patients with drug-sensitive epilepsy with patients with drug-resistant epilepsy to identify risk factors. A multicentric cohort study was conducted between 2019 and 2022. We included patients >18 years-old with epilepsy but excluded psychogenic non-epileptic seizures and less than 2 years of follow-up. We included 128 patients, of whom 46 had drug-resistance epilepsy, and 82 responding to medication. Both groups showed similar characteristics. Febrile seizures (OR: 7.25), focal epilepsy (OR: 2.4), focal seizures with loss of consciousness (OR: 2.36), structural etiology (OR: 2.2) and abnormal MRI (OR: 4.6) were significant risk factors for drug-resistance epilepsy. Following other studies, we observed that factors such as epilepsy type, seizure type, structural etiology, abnormal MRI, and febrile seizure increased the risk for drug-resistance epilepsy, in our population.
Identifiants
pubmed: 37045668
pii: S0025-7753(23)00141-0
doi: 10.1016/j.medcli.2023.03.006
pii:
doi:
Substances chimiques
Anticonvulsants
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
spa
Sous-ensembles de citation
IM
Pagination
547-550Informations de copyright
Copyright © 2023 Elsevier España, S.L.U. All rights reserved.